Intellia Therapeutics Inc sell StockNews.com
Start price
11.05.24
/
50%
€22.51
Target price
11.05.25
-
Performance (%)
-67.08%
End price
12.05.25
€7.41
Summary
This prediction ended on 12.05.25 with a price of €7.41. StockNews_com correctly predicted massive losses of -67.08% for Intellia Therapeutics Inc. StockNews_com has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -30.791% | -30.791% | -47.773% |
| iShares Core DAX® | 1.408% | 0.847% | 27.424% |
| iShares Nasdaq 100 | -1.283% | 5.518% | 11.287% |
| iShares Nikkei 225® | -1.836% | 8.828% | 19.540% |
| iShares S&P 500 | -0.028% | 4.858% | 6.028% |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Intellia Therapeutics Inc
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25
